We are live on ! Find out more
SCCM

Schafer Cullen Capital Management Portfolio holdings

AUM $491M Turnover 78.46%
1-Year Est. Return 41.48%
This Fund
S&P 500
This Quarter Est. Return
+2.36%
1 Year Est. Return
+41.48%
3 Year Est. Return
+28.44%
5 Year Est. Return
+53.22%
10 Year Est. Return
–
AUM
$8.04B
AUM Growth
+$252M
Cap. Flow
+$6.62M
Cap. Flow %
0.08%
Top 10 Hldgs %
22.29%
Holding
290
New
11
Increased
104
Reduced
121
Closed
11
Avg Time Held
2.7 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
2 years

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$18.7M
2
NVS icon
Novartis
NVS
+$18.5M
3
JCI icon
Johnson Controls International
JCI
+$15.7M
4
ADM icon
Archer Daniels Midland
ADM
+$15.1M
5
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$10.9M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$38.8M
2
UN icon
Unilever NV New York Registry Shares
UN
+$28.6M
3
CEO
CNOOC Limited
CEO
+$27.2M
4
MMM icon
3M
MMM
+$24.2M
5
GSK icon
GSK
GSK
+$13.2M

Sector Composition

Rank Sector Weight
1 Miscellaneous 17.84%
2 Financials 15.65%
3 Healthcare 12.88%
4 Consumer Staples 10.55%
5 Industrials 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NVS icon
1
Novartis
NVS
$287B
$232M 2.89%
3,103,156
+260,354
+9% +$18.5M
2013 Q2
16 quarters
UN icon
2
DELISTED
Unilever NV New York Registry Shares
UN
$218M 2.72%
3,949,452
-529,421
-12% -$28.6M
2013 Q2
16 quarters
HSBC icon
3
HSBC
HSBC
$323B
$184M 2.29%
4,339,579
+40,967
+1% +$1.59M
2013 Q2
16 quarters
RDS.B
4
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$176M 2.19%
3,229,630
+196,151
+6% +$10.9M
2013 Q2
16 quarters
JPM icon
5
JPMorgan Chase
JPM
$887B
$171M 2.13%
1,872,480
-85,369
-4% -$7.37M
2013 Q2
16 quarters
BCE icon
6
BCE
BCE
$18.9B
$169M 2.11%
3,760,055
+209,395
+6% +$9.44M
2013 Q2
16 quarters
JNJ icon
7
Johnson & Johnson
JNJ
$611B
$168M 2.1%
1,273,652
-20,101
-2% -$2.56M
2013 Q2
16 quarters
CB icon
8
Chubb
CB
$136B
$161M 2.01%
1,110,238
-29,649
-3% -$4.17M
2013 Q2
16 quarters
WELL icon
9
Welltower
WELL
$169B
$157M 1.95%
2,095,543
-35,330
-2% -$2.58M
2013 Q2
16 quarters
CSCO icon
10
Cisco
CSCO
$430B
$154M 1.91%
4,913,113
+59,135
+1% +$1.93M
2013 Q2
16 quarters
MSFT icon
11
Microsoft
MSFT
$4.01T
$152M 1.89%
2,199,334
-92,175
-4% -$6.33M
2013 Q2
16 quarters
MO icon
12
Altria Group
MO
$123B
$151M 1.88%
2,030,191
-136,012
-6% -$9.95M
2013 Q2
16 quarters
DEO icon
13
Diageo
DEO
$52.4B
$148M 1.84%
1,235,808
-20,459
-2% -$2.44M
2013 Q2
16 quarters
AZN icon
14
AstraZeneca
AZN
$259B
$144M 1.79%
2,106,132
+5,001
+0.2% +$327K
2013 Q2
16 quarters
BA icon
15
Boeing
BA
$148B
$144M 1.79%
725,815
-41,315
-5% -$7.69M
2013 Q2
16 quarters
CVX icon
16
Chevron
CVX
$431B
$143M 1.78%
1,367,999
+83,246
+6% +$8.82M
2013 Q2
16 quarters
DD icon
17
DELISTED
Du Pont De Nemours E I
DD
$141M 1.75%
1,741,586
-31,260
-2% -$2.5M
2013 Q2
16 quarters
MRK icon
18
Merck
MRK
$365B
$140M 1.74%
2,286,366
-63,926
-3% -$3.89M
2013 Q2
16 quarters
T icon
19
AT&T
T
$161B
$139M 1.73%
4,890,314
+65,984
+1% +$1.95M
2013 Q2
16 quarters
WFC icon
20
Wells Fargo
WFC
$249B
$137M 1.71%
2,480,541
+57,401
+2% +$3.08M
2013 Q2
16 quarters
NEE icon
21
NextEra Energy
NEE
$164B
$131M 1.63%
3,736,084
-211,316
-5% -$7.22M
2013 Q2
16 quarters
TRV icon
22
Travelers Companies
TRV
$79.4B
$130M 1.62%
1,028,604
-13,048
-1% -$1.61M
2013 Q2
16 quarters
GE icon
23
GE Aerospace
GE
$321B
$130M 1.61%
1,001,850
+26,619
+3% +$3.65M
2013 Q2
16 quarters
MET icon
24
MetLife
MET
$63.6B
$122M 1.51%
2,482,314
+148,160
+6% +$6.87M
2013 Q2
16 quarters
PFE icon
25
Pfizer
PFE
$169B
$116M 1.44%
3,641,808
-68,566
-2% -$2.16M
2013 Q2
16 quarters
1
2 3 4 5

Similar funds

CNC
Camden National Corporation Camden, Maine $502M AUM
SRAM
Stone Ridge Asset Management New York $475M AUM
PA
Paracle Advisors Mercer Island, Washington $551M AUM 50.34% 1-Year Est. Return
FBP
Flippin Bruce & Porter Lynchburg, Virginia $553M AUM 70.43% 1-Year Est. Return
SGMP
Spark Growth Management Partners Boston, Massachusetts $591M AUM
RG
Rikoon Group Santa Fe, New Mexico $376M AUM 56.75% 1-Year Est. Return
LFA
Lighthouse Financial Advisors New Market, Maryland $330M AUM 62.92% 1-Year Est. Return
RHFI
Reilly Herbert Faulkner III $316M AUM 51.88% 1-Year Est. Return

Schafer Cullen Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Schafer Cullen Capital Management held 290 positions worth $8.04B, up 3.2% from $7.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Schafer Cullen Capital Management's Q2 2017 filing shows 11 new, 104 increased, 121 reduced and 11 closed positions. Its largest new stake was SK Telecom: 234,433 shares worth $9.91M. The largest sale was Philip Morris, an estimated $38.8M.

By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Schafer Cullen Capital Management's largest Q2 2017 buy was SK Telecom: 234,433 shares worth $9.91M.
  • Schafer Cullen Capital Management added most to ExxonMobil in Q2 2017, an estimated $18.7M increase.
  • Schafer Cullen Capital Management's biggest Q2 2017 reduction was Philip Morris, cutting an estimated $38.8M.
  • Schafer Cullen Capital Management fully exited CNOOC Limited in Q2 2017, selling an estimated $27.2M.
  • Schafer Cullen Capital Management's ten largest holdings make up 22% of its $8.04B portfolio in Q2 2017.
  • Schafer Cullen Capital Management opened 11 new positions and closed 11 in Q2 2017.
  • Schafer Cullen Capital Management's portfolio value rose 3.2% quarter-over-quarter to $8.04B.

Based on Schafer Cullen Capital Management's 13F filing for Q2 2017, filed 16 Aug 2017.